97 related articles for article (PubMed ID: 18094886)
21. RAPD analysis with the primer L15996 of Brazilian clinical and environmental Cryptococcus neoformans isolates.
Andrade-Silva L; Ferreira-Paim K; Mora DJ; da Silva PR; Andrade AA; Lages-Silva E; Pedrosa AL; Silva-Vergara ML
Mycopathologia; 2012 Jul; 174(1):53-9. PubMed ID: 22249603
[TBL] [Abstract][Full Text] [Related]
22. Current scenario of cryptococcosis and antifungal susceptibility pattern in India: a cause for reappraisal.
Capoor MR; Mandal P; Deb M; Aggarwal P; Banerjee U
Mycoses; 2008 May; 51(3):258-65. PubMed ID: 18399907
[TBL] [Abstract][Full Text] [Related]
23. Genetic relatedness and diversity of Cryptococcus neoformans strains in the Maltese Islands.
Lo Passo C; Pernice I; Gallo M; Barbara C; Luck FT; Criseo G; Pernice A
J Clin Microbiol; 1997 Mar; 35(3):751-5. PubMed ID: 9041427
[TBL] [Abstract][Full Text] [Related]
24. Dynamics of Cryptococcus neoformans-macrophage interactions reveal that fungal background influences outcome during cryptococcal meningoencephalitis in humans.
Alanio A; Desnos-Ollivier M; Dromer F
mBio; 2011; 2(4):. PubMed ID: 21828220
[TBL] [Abstract][Full Text] [Related]
25. Genotypic diversity of environmental Cryptococcus neoformans isolates from Northern Portugal.
Ferreira AS; Sampaio A; Maduro AP; Silva I; Teles F; Martins Mda L; Inácio J
Mycoses; 2014 Feb; 57(2):98-104. PubMed ID: 23848429
[TBL] [Abstract][Full Text] [Related]
26. Karyotype instability in Cryptococcus neoformans infection.
Fries BC; Chen F; Currie BP; Casadevall A
J Clin Microbiol; 1996 Jun; 34(6):1531-4. PubMed ID: 8735111
[TBL] [Abstract][Full Text] [Related]
27. Molecular subtypes and antifungal susceptibilities of serial Cryptococcus neoformans isolates in human immunodeficiency virus-associated Cryptococcosis. Cryptococcal Disease Active Surveillance Group.
Brandt ME; Pfaller MA; Hajjeh RA; Graviss EA; Rees J; Spitzer ED; Pinner RW; Mayer LW
J Infect Dis; 1996 Oct; 174(4):812-20. PubMed ID: 8843221
[TBL] [Abstract][Full Text] [Related]
28. First isolation of Cryptococcus neoformans genotype VNI MAT-alpha from wood inside hollow trunks of Hymenaea courbaril.
Castro e Silva DM; Santos DC; Martins MA; Oliveira L; Szeszs MW; Melhem MS
Med Mycol; 2016 Jan; 54(1):97-102. PubMed ID: 26337089
[TBL] [Abstract][Full Text] [Related]
29. Molecular typing of environmental Cryptococcus neoformans/C. gattii species complex isolates from Manaus, Amazonas, Brazil.
Alves GS; Freire AK; Bentes Ados S; Pinheiro JF; de Souza JV; Wanke B; Matsuura T; Jackisch-Matsuura AB
Mycoses; 2016 Aug; 59(8):509-15. PubMed ID: 27005969
[TBL] [Abstract][Full Text] [Related]
30. Antifungal susceptibilities, varieties, and electrophoretic karyotypes of clinical isolates of Cryptococcus neoformans from Brazil, Chile, and Venezuela.
Calvo BM; Colombo AL; Fischman O; Santiago A; Thompson L; Lazera M; Telles F; Fukushima K; Nishimura K; Tanaka R; Myiajy M; Moretti-Branchini ML
J Clin Microbiol; 2001 Jun; 39(6):2348-50. PubMed ID: 11376089
[TBL] [Abstract][Full Text] [Related]
31. Genetic and pathological characteristics of Cryptococcus gattii and Cryptococcus neoformans var. neoformans from meningoencephalitis in autochthonous goats and mouflons, Sardinia, Italy.
Maestrale C; Masia M; Pintus D; Lollai S; Kozel TR; Gates-Hollingsworth MA; Cancedda MG; Cabras P; Pirino S; D'Ascenzo V; Ligios C
Vet Microbiol; 2015 Jun; 177(3-4):409-13. PubMed ID: 25840469
[TBL] [Abstract][Full Text] [Related]
32. Genotyping of Cryptococcus neoformans isolated from captive birds in Uberaba, Minas Gerais, Brazil.
Ferreira-Paim K; Andrade-Silva L; Mora DJ; Pedrosa AL; Rodrigues V; Silva-Vergara ML
Mycoses; 2011 Sep; 54(5):e294-300. PubMed ID: 20492533
[TBL] [Abstract][Full Text] [Related]
33. Molecular epidemiology and in vitro antifungal susceptibility testing of 108 clinical Cryptococcus neoformans sensu lato and Cryptococcus gattii sensu lato isolates from Denmark.
Hagen F; Hare Jensen R; Meis JF; Arendrup MC
Mycoses; 2016 Sep; 59(9):576-84. PubMed ID: 27061834
[TBL] [Abstract][Full Text] [Related]
34. Genotypes of Cryptococcus neoformans and Cryptococcus gattii as agents of endemic cryptococcosis in Teresina, Piauí (northeastern Brazil).
Martins LM; Wanke B; Lazéra Mdos S; Trilles L; Barbosa GG; Macedo RC; Cavalcanti Mdo A; Eulálio KD; Castro JA; Silva AS; Nascimento FF; Gouveia VA; Monte SJ
Mem Inst Oswaldo Cruz; 2011 Sep; 106(6):725-30. PubMed ID: 22012227
[TBL] [Abstract][Full Text] [Related]
35. Karyotyping of Cryptococcus neoformans as an epidemiological tool.
Perfect JR; Ketabchi N; Cox GM; Ingram CW; Beiser CL
J Clin Microbiol; 1993 Dec; 31(12):3305-9. PubMed ID: 8308124
[TBL] [Abstract][Full Text] [Related]
36. Molecular characterization and antifungal susceptibility of Cryptococcus neoformans strains collected from a single institution in Lima, Peru.
Bejar V; Tello M; García R; Guevara JM; Gonzales S; Vergaray G; Valencia E; Abanto E; Ortega-Loayza AG; Hagen F; Gutierrez EL
Rev Iberoam Micol; 2015; 32(2):88-92. PubMed ID: 25556051
[TBL] [Abstract][Full Text] [Related]
37. Molecular characterization and evaluation of virulence factors of Cryptococcus laurentii and Cryptococcus neoformans strains isolated from external hospital areas.
Andrade-Silva L; Ferreira-Paim K; Silva-Vergara ML; Pedrosa AL
Fungal Biol; 2010; 114(5-6):438-45. PubMed ID: 20943154
[TBL] [Abstract][Full Text] [Related]
38. Random amplified polymorphic DNA analysis of clinically and environmentally isolated Cryptococcus neoformans in Nagasaki.
Yamamoto Y; Kohno S; Koga H; Kakeya H; Tomono K; Kaku M; Yamazaki T; Arisawa M; Hara K
J Clin Microbiol; 1995 Dec; 33(12):3328-32. PubMed ID: 8586730
[TBL] [Abstract][Full Text] [Related]
39. Molecular typing and antifungal susceptibility of clinical and environmental Cryptococcus neoformans species complex isolates in Goiania, Brazil.
Souza LK; Souza Junior AH; Costa CR; Faganello J; Vainstein MH; Chagas AL; Souza AC; Silva MR
Mycoses; 2010 Jan; 53(1):62-7. PubMed ID: 19500261
[TBL] [Abstract][Full Text] [Related]
40. Cryptococcus neoformans and C. gattii isolates from both HIV-infected and uninfected patients: antifungal susceptibility and outcome of cryptococcal disease.
Nascimento E; Vitali LH; Kress MRVZ; Martinez R
Rev Inst Med Trop Sao Paulo; 2017; 59():e49. PubMed ID: 28793019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
